Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Identification of second breast cancer gene announced
March 3rd, 2005
SEQUENOM, Inc., (NASDAQ:SQNM) announced the discovery of genetic variations in the gene encoding the nuclear mitotic apparatus protein (NuMA) that affect breast cancer risk. Published in the online early edition of the Proceedings of the National Academy of Sciences of the USA (PNAS), the study entitled "Association of the NuMA region on chromosome 11q13 with breast cancer susceptibility" reports that individuals with a coding variation in the NuMA gene have more than a 2-fold higher risk of developing breast cancer than those without it. This risk is increased to more than 4-fold for cases with a family history of cancer. The company...
Source: Women's Health Weekly (2005-03-03)
|
